p53 Mutation and Survival in Head and Neck Cancer
Author Information
Author(s): H Mineta, A Borg, M Dictor, P Wahlberg, J Akervall, J Wennerberg
Primary Institution: University Hospital, Lund, Sweden
Hypothesis
The study aims to evaluate the correlation between p53 mutation and survival in head and neck squamous cell carcinoma.
Conclusion
p53 mutation status is a significant prognostic factor for survival in head and neck squamous cell carcinoma, while p53 overexpression does not correlate with survival.
Supporting Evidence
- Median survival among mutated cases was 12.5 months compared with over 160 months among non-mutated patients.
- 12 tumors exhibited gene mutation, while 65 did not.
- Immunohistochemical positivity for p53 was found in 57.1% of the analyzed tumors.
Takeaway
This study found that having a mutation in the p53 gene is linked to shorter survival in head and neck cancer, while just having more of the p53 protein doesn't help predict how long someone will live.
Methodology
The study analyzed archival tissue from 77 tumors for p53 protein expression using immunohistochemistry and for mutations using single-stranded conformation polymorphism followed by DNA sequencing.
Limitations
The study's sample size is relatively small, and the analysis is based on archival tissue which may affect the quality of the results.
Participant Demographics
The male to female ratio was 2.2:1, with 39% of patients in stage I-II and 61% in stage III-IV.
Statistical Information
P-Value
p<0.005
Confidence Interval
95% confidence interval: 3.21-30.34
Statistical Significance
p<0.005
Want to read the original?
Access the complete publication on the publisher's website